Session: Protein Engineering I - Therapeutics (2011 Annual Meeting)

Tuesday, October 18, 2011: 8:30 AM

M100 H (Minneapolis Convention Center)

Description:

This session will focus on protein engineering for therapeutic applications with an emphasis on emerging topics and recent successes. Possible areas of interest include, but are not limited to, (1) advances in protein-based therapeutics, (2) proteins for cellular targeting and imaging, and (3) proteins involved in disease pathology.

Sponsor:

Bioengineering

Chair:

Karl E. Griswold
Email: Karl.E.Griswold@Dartmouth.edu

Co-Chair:

Joel L. Kaar
Email: joel.kaar@colorado.edu

8:30 AM

(256a) The Exploitation of S. Cerevisiae - Improved Understanding and Optimal Yields of Single-Chain Antibody Fragment (scFv) 4-4-20
Carissa L. Young, Zachary T. Britton, Ronald W. Maurer III and Anne S. Robinson

8:50 AM

(256b) Engineering Anti-Prion Scfv for the Treatment of Prion Diseases
Kyle M. Doolan, Ryan J. O'Boyle and David W. Colby

9:10 AM

(256c) Protease-Activated Antibodies for Diagnostics and Therapy
Patrick S. Daugherty and Tobias Schoep

9:30 AM

(256d) Engineered Monospecific and Bispecific Proteins That Target Tumor Vascular Receptors As In Vivo Imaging Agents
Sarah J. Moore, Cheuk L. Leung, Heidi Norton, Niv Papo and Jennifer R. Cochran

9:50 AM

Break

10:00 AM

(256e) A Protein Therapeutic Modality Founded On Molecular Regulation
Chapman M. Wright, R. Clay Wright, James R. Eshleman and Marc Ostermeier

10:20 AM

(256f) Transferrin Mediated Drug Delivery to Brain
Divya Chandra and Pankaj Karande

10:40 AM

(256g) Protegrin Has Distinct Mechanisms of Action On Prokaryotes and Eukaryotes As Defined by Unique Morphological Changes
Katherine G. Volzing and Yiannis Kaznessis

See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division

<< Previous Session | Next Session >>